At Hetero, we aim at bringing a wide basket of anti-cancer products at affordable prices to besides positively impacting the lives of millions of cancer patients in terms of health and economic aspects.

Over the years, Hetero has been building a global franchise of oncology products both in APIs and finished dosages. We have always continued to extend our anti-cancer portfolio and now we have more than 35 drugs for treating various types of cancer.The company has 3 dedicated state-of-the-art manufacturing facility in India and China producing affordable anti-cancer drugs in different dosage forms.

Hetero has recently started its operations at Furen Hetero Onco-therapeutics in China – A JV initiative between Hetero and Furen Medicines Group, China which is envisaged to help us rapidly expand our presence in Global Oncology Therapeutics.